Heranova Lifesciences

#Endometriosis is a gynecological condition that affects more than 10% of women between the ages of 15 and 44. It occurs when endometrial-like tissue grows outside the uterus, often on the fallopian tubes, ovaries, or other pelvic structures. Symptoms are diverse and may include severe menstrual cramps that worsen over time, chronic pelvic or lower back pain, dyspareunia (pain during intercourse), and gastrointestinal disturbances such as bloating, constipation, or diarrhea. In some cases, infertility may also be a complication of this condition. Learn how to recognize these symptoms and other endometriosis-related insights in this article from Essentia Health: https://bit.ly/40hbwg9 Heranova’s HerResolve test offers a non-invasive, blood-based diagnostic solution for endometriosis. The test intends to provide a clear detected/not detected result enabling more personalized care for women suffering from endometriosis. For more information, visit Heranova.com #Heranova #HerResolve #WomensHealth

We extend our sincere gratitude to the American Society for Reproductive Medicine - ASRM for the opportunity to engage with leading professionals in reproductive medicine at #ASRM24. It was an invaluable experience to share insights on HerResolve, our innovative, non-invasive, blood-based diagnostic solution for the detection of #endometriosis. Heranova is deeply committed to advancing women’s health through close collaboration with clinical professionals. By prioritizing early and accurate diagnosis, we aim to empower women with the clarity and peace of mind they deserve. We look forward to continuing these impactful conversations and participating in ASRM again next year. For more information on endometriosis and HerResolve, please visit us at Heranova.com #Heranova #HerResolve #WomensHealth

#Endometriosis affects 10% of women worldwide, often going undiagnosed or misdiagnosed for years. Traditionally linked to retrograde menstruation, new research highlights the role of endometriosis-associated macrophages (EAMs) in the disease's progression. These immune cells contribute to pain and tissue growth, offering new therapeutic targets. Emerging treatments aim to reprogram EAMs, potentially transforming the way endometriosis is treated. By shifting the focus from menstruation to immune dysfunction, researchers hope to reduce the stigma and improve timely diagnosis and care for those affected. Read more here: https://bit.ly/4dMjwcg Heranova is advancing this shift in understanding by developing non-invasive diagnostic solutions, such as HerResolve, to detect endometriosis earlier and help bridge the gap between disease onset and timely, effective care. Learn more at Heranova.com #Heranova #WomensHealth #HerResolve #Immunotherapy

According to the The National Institutes of Health, 30-50% of women with #endometriosis are infertile, and 25-50% of infertile women have endometriosis. Early detection and accurate diagnosis are crucial when endometriosis is suspected, as they can help minimize complications and improve fertility outcomes. With advances in non-invasive diagnostic tools like HerResolve, timely identification of endometriosis is more accessible than ever, empowering women to make informed decisions about their health. Visit us at Heranova.com to learn more about endometriosis, infertility, and how we are advancing non-invasive diagnostic solutions like HerResolve. #Heranova #WomensHealth #HerResolve

Heranova is live at #ASRM24 in Denver! Visit booth #229 to meet our team and learn about HerResolve, our innovative, non-invasive blood test for endometriosis detection. #ASRM24 #Heranova #HerResolve #Endometriosis

Heranova is at #ASRM24 in Denver, Colorado. Stop by booth #229 to meet our expert team and learn more about HerResolve, our non-invasive, blood-based diagnostic test to confirm the presence or absence of endometriosis. Explore how we’re driving progress in women’s health with pioneering research and innovative solutions. We're excited to share our developments and engage with you at the event. Don't miss the chance to connect with us!  #ASRM24 #Heranova #HerResolve #Endometriosis 

#Endometriosis affects 10-15% of women of child-bearing age, yet much remains unknown about its causes. Recent research confirms a genetic link, with relatives of those with endometriosis being 5-7 times more likely to have it. While family history can increase risk, it's not a guarantee. If you have concerns, discussing your family history with a gynecologist can help guide evaluation and monitoring for symptoms. Learn more here in this article from SheKnows: https://bit.ly/3BCXpHE At #Heranova, we stand in solidarity with women everywhere suffering from this misunderstood condition. While family history can provide some insights, our non-invasive, blood-based endometriosis test, #HerResolve, confirms the presence or absence of endometriosis. Learn more by visiting us at Heranova.com #WomensHealth

U.S. scientist John Hopfield and British-Canadian computer scientist Geoffrey Hinton have been awarded the 2024 Nobel Prize in Physics for their pioneering contributions to machine learning, which have driven the rapid growth of artificial intelligence. Their work laid the foundation for AI technologies revolutionizing fields like healthcare and scientific research. Notably, AI holds the potential to significantly improve women's health by aiding in the diagnosis and treatment of conditions like #endometriosis. Read more here: https://bit.ly/3BEbV24 At Heranova, we are leveraging the power of AI and developing #HerResolve, our non-invasive, blood-based diagnostic solutions to accurately detect the presence or absence of endometriosis. Learn more at Heranova.com #WomensHealth #Heranova

Heranova's Chief Medical Officer, Farideh Bischoff, PhD, and Chief Scientific Officer, Marcel van Duin, PhD, will be attending the ASRM 2024 Annual Meeting from October 19-23 in Denver, Colorado (booth #229). If you would like to schedule a meeting with Dr. Bischoff or Dr. van Duin during the event, please reach out to clinicalaffairs@heranova.com. We look forward to discussing our innovative blood-based solution for detecting endometriosis, HerResolve, sharing our latest developments, and exploring collaborations. #ASRM24 #Heranova #HerResolve #Endometriosis #WomensHealth

U.S. scientists Victor Ambros and Gary Ruvkun have won the 2024 Nobel Prize in Medicine for their discovery of microRNA, a crucial component in gene regulation. Their groundbreaking work continues to create vast potential applications for human health. Read more here: https://bit.ly/3zIohpp The application of microRNA extends to diagnostic tools, such as as #HerResolve, a blood-based test to confirm the presence or absence of #endometriosis. This revolutionizing innovation potentially offers a non-invasive approach to detection and management of endometriosis. Visit Heranova.com to learn more. #Heranova #WomensHealth